Literature DB >> 31352311

Boosting often overlooked long wavelength emissions of rare-earth nanoparticles for NIR-II fluorescence imaging of orthotopic glioblastoma.

Zheng Liu1, Feng Ren1, Hao Zhang1, Qiang Yuan2, Zhilin Jiang1, Hanghang Liu1, Qiao Sun1, Zhen Li3.   

Abstract

Rare-earth nanoparticles (RE NPs) with narrow long wavelength emissions have been recently investigated for their potential application for fluorescence imaging in the second near-infrared window (NIR-II). Previously these RE NPs have a very limited application in the diagnosis and treatment of deep-seated tumors such as brain tumors, due to their weak fluorescence in the range of 1300-1700 nm. Herein, we report a significant enhancement of more than 10 times regular emission of NaNdF4 nanoparticles at 1340 nm wavelength by coating them with an inert layer of NaLuF4, followed by sensitizing with a near-infrared dye (IR-808). We deliver these highly bright nanoparticles into the brain by using focused ultrasound to temporarily open the blood-brain barrier (BBB), and then detect the orthotopic glioblastoma by fluorescence imaging at 1340 nm. The images obtained from long wavelength fluorescence (i.e. 1340 nm) exhibited better resolution and contrast compared to the short wavelength fluorescence (i.e. 1060 nm). Our study not only provides insights for enhancing often overlooked emissions of rare-earth nanoparticles for NIR-II fluorescence imaging of deep-seated tumors, but also demonstrates great potential of focused ultrasound based technology in delivering nanotheranostic agents.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Core-shell nanoparticles; Down-conversion; Dye-sensitization; NIR-II fluorescence imaging; Orthotopic glioblastoma

Year:  2019        PMID: 31352311     DOI: 10.1016/j.biomaterials.2019.119364

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

Review 1.  Rare-earth based materials: an effective toolbox for brain imaging, therapy, monitoring and neuromodulation.

Authors:  Zheng Wei; Yawei Liu; Bo Li; Jingjing Li; Shuang Lu; Xiwen Xing; Kai Liu; Fan Wang; Hongjie Zhang
Journal:  Light Sci Appl       Date:  2022-06-10       Impact factor: 20.257

Review 2.  Recent advances in near-infrared II imaging technology for biological detection.

Authors:  Nan-Nan Zhang; Chen-Ying Lu; Min-Jiang Chen; Xiao-Ling Xu; Gao-Feng Shu; Yong-Zhong Du; Jian-Song Ji
Journal:  J Nanobiotechnology       Date:  2021-05-10       Impact factor: 10.435

Review 3.  Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours.

Authors:  Chiara Ferraris; Roberta Cavalli; Pier Paolo Panciani; Luigi Battaglia
Journal:  Int J Nanomedicine       Date:  2020-04-30

Review 4.  Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases.

Authors:  Wenxian Du; Lingling Zhou; Qiang Zhang; Xin Liu; Xiaoer Wei; Yuehua Li
Journal:  Molecules       Date:  2021-12-03       Impact factor: 4.411

Review 5.  Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics.

Authors:  Ming-Hsien Chan; Wen-Tse Huang; Aishwarya Satpathy; Ting-Yi Su; Michael Hsiao; Ru-Shi Liu
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

6.  Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation.

Authors:  Jan-Niklas May; Susanne K Golombek; Maike Baues; Anshuman Dasgupta; Natascha Drude; Anne Rix; Dirk Rommel; Saskia von Stillfried; Lia Appold; Robert Pola; Michal Pechar; Louis van Bloois; Gert Storm; Alexander J C Kuehne; Felix Gremse; Benjamin Theek; Fabian Kiessling; Twan Lammers
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.